Ecallantide (DX-88) TFA, a specific recombinant plasma kallikrein inhibitor, directly inhibits bradykinin production and is indicated for the prevention of acute angioedema attacks [1].
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted